Press Releases
Public Relations: Andrew Noble
November 10, 2025
New
EpiCypher Launches CUTANA® Cloud, a Powerful Epigenomic Data Analysis Platform
EpiCypher’s new bioinformatics platform, powered by DNAnexus, accelerates data analysis for leading chromatin mapping technologies including CUT&RUN and CUT&Tag.
Read More
October 22, 2025
DNAnexus Honored with Frost & Sullivan’s 2025 Technology Innovation Leadership Award
DNAnexus earned recognition from Frost & Sullivan for its leadership in precision health informatics. The award highlights its groundbreaking platform for integrating complex clinical, multi-omics, and real-world data to deliver secure, actionable insights.
Read More
September 11, 2025
DNAnexus and Oracle Join Forces to Deliver Genomic Insights at the Point of Care
Collaboration to enable healthcare professionals to access and interpret genomic data alongside patient medical history within Oracle Health EHR.
Read More
August 27, 2025
DNAnexus Enhances Leadership to Fuel AI Innovation and Biopharma Expansion
Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx
Read More
August 14, 2025
DNAnexus & Boehringer Ingelheim Named 2025 Prix Galien USA Nominee in Best Digital Health Solution for Project PRISM/Project CRYPTx
This recognition highlights an emerging model for dynamic, cloud-based regulatory collaboration.
Read More
News
February 02, 2026
New
Accelerating the drug regulatory process through a federated cloud ecosystem
Cloud-based regulatory platforms are transitioning from pilots to practical solutions. Sustainable adoption now relies on global coordination, continued trust and a shift towards federated, interoperable models.
Read More
January 21, 2026
The Top Healthcare Technology CEOs of 2025
The Healthcare Technology Report named DNAnexus CEO Thomas Laur as one of the Top Healthcare Technology CEOs of 2025. He was recognized for his leadership of our advanced platform that speeds critical decisions, reduces administrative drag, and supports research and care delivery across hospitals, employers, payers, and patients.
Read More
January 21, 2026
theCUBE + NYSE Wired: MedTech Unplugged Interview with Thomas Laur
Thomas spoke with theCUBE’s John Furrier as part of the CUBE + NYSE Wired: MedTech Unplugged: The Future of AI in Healthcare & Life Sciences event. They discuss why “omics” is becoming a core data object in modern care and what it takes to make precision medicine operational across the healthcare continuum and why AI’s upside in healthcare depends on more organized, omics-enabled data.
Read More
January 20, 2026
How DNAnexus is enabling precision medicine from research to the point of care
DNAnexus is pushing precision medicine out of research silos to improve care delivery. As CEO Thomas Laur puts it, “The future isn’t moving data into one big bucket. It’s moving algorithms to federated data,” enabling distributed clinical decisions at scale.
Read More
January 08, 2026
The ADAPT learning cancer treatment system: ARPA-H’s initiative to revolutionize cancer therapy
ADAPT is a nationwide initiative to transform cancer care by detecting and responding to tumor evolution in real time. Integrating multimodal data, interpretable AI, and an evolutionary clinical trial platform, ADAPT predicts emerging resistance traits and guides treatment adjustments as tumors change.
Read More
"Collaboration is vital to advancing scientific discovery. We are excited to partner with Microsoft and DNAnexus to create infrastructure and tools to share data and accelerate progress toward finding cures for pediatric cancer and other life-threatening diseases."
James R. Downing
President & CEO
St. Judes Children’s Research Hospital